Haolzyme Therapeutics

Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech
Fierce Biotech
Tue, 03/29/22 - 10:36 am
Roche
Chugai
drug delivery
subcutaneous drug delivery
Haolzyme Therapeutics
Enhanze